ROXICET 5/500 Drug Patent Profile
✉ Email this page to a colleague
When do Roxicet 5/500 patents expire, and when can generic versions of Roxicet 5/500 launch?
Roxicet 5/500 is a drug marketed by Roxane and is included in one NDA.
The generic ingredient in ROXICET 5/500 is acetaminophen; oxycodone hydrochloride. There are sixty-six drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the acetaminophen; oxycodone hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ROXICET 5/500?
- What are the global sales for ROXICET 5/500?
- What is Average Wholesale Price for ROXICET 5/500?
Summary for ROXICET 5/500
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 181 |
| Clinical Trials: | 1 |
| Patent Applications: | 4,196 |
| DailyMed Link: | ROXICET 5/500 at DailyMed |
Recent Clinical Trials for ROXICET 5/500
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Institute on Drug Abuse (NIDA) | N/A |
| University of Kentucky | N/A |
| Merck Sharp & Dohme Corp. | N/A |
US Patents and Regulatory Information for ROXICET 5/500
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Roxane | ROXICET 5/500 | acetaminophen; oxycodone hydrochloride | TABLET;ORAL | 089775-001 | Jan 12, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
